24 HR amantadine 129 MG Extended Release Oral Tablet [Osmolex]
RxNorm concept 2044720, branded drug (sbd). Prescribable name: Osmolex ER 129 MG 24HR Extended Release Oral Tablet.
- RxCUI
- 2044720
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2044720 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
24 HR Osmolex 129 MG Extended Release Oral Tablet; Osmolex 129 MG (as amantadine HCl 160 MG) 24 HR Extended Release Oral Tablet
Related concepts
- amantadine 129 MG (SCDC, consists of)
- amantadine 129 MG [Osmolex] (SBDC, consists of)
- {30 (24 HR amantadine 129 MG Extended Release Oral Tablet [Osmolex]) / 30 (24 HR amantadine 193 MG Extended Release Oral Tablet [Osmolex]) } Pack [Osmolex 322 MG Daily Dosing] (BPCK, contained in)
- Extended Release Oral Tablet (DF, has dose form)
- Osmolex (BN, has ingredient)
- 24 HR amantadine 129 MG Extended Release Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 68025007590
- 70482007530
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2044720 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2044720 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2044720. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.